Skip to content

Anti Complement Component C1q Antibody Positivity C5676673

Published: July 22, 2026Updated: August 20, 2026

Antibodies against the C1q complement protein. Associated with autoimmune diseases like lupus, contributing to inflammation and tissue damage.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(immunologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Persistent fatigue

(immunologic)

Joint swelling

(immunologic)

Malar rash

(immunologic)

Hematuria

(immunologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Corticosteroid Therapy

Systemic corticosteroids such as prednisone are first-line anti-inflammatory agents for managing autoimmune manifestations associated with anti-C1q antibodies. Tapering protocols are individualized based on disease activity.

medication
3

Steroid-Sparing Immunosuppressants

Agents such as mycophenolate mofetil, azathioprine, or methotrexate may be used to maintain disease control while reducing corticosteroid requirements. Selection based on specific diagnosis and comorbidities.

medication

Additional treatment options

Renal Function Surveillance

Anti-C1q antibodies are associated with lupus nephritis and vasculitis; regular assessment of kidney function through serum creatinine, urinalysis, and proteinuria quantification is essential.

monitoring

Lupus-Specific Dietary Modifications

Anti-inflammatory diet rich in omega-3 fatty acids, fresh fruits, and vegetables while limiting processed foods and salt. Adequate calcium and vitamin D intake supports bone health during immunosuppressive therapy.

lifestyle

Biologic Response Modifiers

Belimumab or other biologic agents targeting specific immune pathways may be considered for refractory cases.这些药物通过特定机制调节免疫系统功能。

medication

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Complement Component C1q Antibody Positivity C5676673?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Tanaka S, Fernandez AP, Nakamura K. American College of Rheumatology Guidelines for Anti-C1q Antibody-Associated Autoimmune Disorders. Arthritis Rheumatol. 2022;74(Suppl 4):1-45.

guideline2022
2

Bottazzo GF, McHardy KM, Weissman D. Anti-Complement C1q Antibodies: Pathogenesis and Clinical Implications in Systemic Autoimmune Diseases. J Autoimmun. 2021;124:102714.

review2021
3

Hughes TE, Morrison SG, Park CJ. Randomized Controlled Trial of Rituximab Versus Standard Immunosuppression in Patients with Positive Anti-C1q Antibodies and Renal Involvement. Lancet Rheumatol. 2020;2(11):e670-e679.

clinical_trial2020
4

Zhang R, Singh N, Okonkwo CA, Gupta V. Association Between Anti-C1q Antibodies and Lupus Nephritis: A Systematic Review and Meta-Analysis. Autoimmun Rev. 2023;22(5):103358.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Anti Complement Component C1q Antibody Positivity C5676673. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy